Navigation Links
2010 UCB Rheumatoid Arthritis Family Scholarship Winners Announced
Date:11/18/2010

the program can be found at www.ReachBeyondRA.com as well as on Facebook.

UCB offers support to people living with chronic diseases, along with their families and friends, through a broad range of programs that foster independence and empowerment.  The UCB Family Scholarship Program™ is just one such program; for information on others, visit www.UCB-usa.com/patients.

About Rheumatoid ArthritisRheumatoid arthritis (RA) affects more than 1.3 million Americans, and it is estimated that 5 million people suffer from RA globally. Prevalence is not split evenly between genders, since women are three times more likely to be affected than men. Although RA can affect people of all ages, the onset of the disease usually occurs between 35-55 years of age.For Further Information:Bert Kelly, Communications and Public Relations Manager, UCBT: 770.970.8491, Bert.Kelly@ucb.comAbout UCBUCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8 000 people in about 40 countries, the company generated revenue of EUR 3.1 billion in 2009. UCB is listed on Euronext Brussels (symbol: UCB).

For further information on UCB products, please visit www.UCB.com.

Forward-looking statementsThis press release contains forward-looking statements based on current plans, estimates and beliefs of management. Such statements are subject to risks and uncertainties that may cause actual results to
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments
2. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
3. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
4. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
5. Two Pivotal Phase III Studies for Roches ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms
6. Trubion Pharmaceuticals Announces Presentation of Positive Data From Phase IIb and Re-treatment Studies With TRU-015 in Patients With Rheumatoid Arthritis
7. Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
8. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
9. Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept)
10. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
11. MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)... - Health Canada is working with the Canadian manufacturers ... information regarding the risk of serious cardiovascular side effects ... used at high doses (at or above 2400 mg/day). ... Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) ... inflammation. The majority of ibuprofen products in ...
(Date:4/23/2015)... 2015 Nektar Therapeutics (Nasdaq: NKTR ) will ... 31, 2015 on Thursday, April 30, 2015, after the close ... chief executive officer, will host a conference call to review ... Pacific Time (PT). The press release and ... accessed through a link that is posted on the home ...
(Date:4/23/2015)... 23, 2015 Surna, Inc. (OTCQB: SRNA), a ... art equipment and systems for controlled environment agriculture ... cultivation, will host a shareholder conference call to ... at 4:15 PM Eastern Standard Time/1:15 PM Pacific ... will be listen-in only, but will include a ...
Breaking Medicine Technology:Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 2Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 3Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 4Nektar to Announce Financial Results for the First Quarter 2015 on Thursday, April 30, 2015, After Close of U.S.-Based Financial Markets 2Surna, Inc. Announces Shareholder Conference Call 2Surna, Inc. Announces Shareholder Conference Call 3
...  Results from the combined analysis of two European ... 3rd European Lung Cancer Conference in Geneva, Switzerland. ... samples from advanced non-squamous non-small cell lung cancer ... plus erlotinib.  Results showed that the VeriStrat test ...
... (NASDAQ: STAA ), the leading developer, manufacturer and ... that the total number of its Visian® ICL implants in ... have been the Visian Toric ICL which is approved in ... of the U.S. The Company will highlight the benefits of ...
Cached Medicine Technology:VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer 2VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer 3STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress 2STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress 3STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress 4STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress 5
(Date:4/26/2015)... In an article published last month in Ergonomics ... occurring during the use of handheld electronic devices such as ... use of a tablet increases mechanical demand on neck muscles ... than when the neck is in a neutral position. Perhaps ... out the potential hazards of overuse of mobile technology may ...
(Date:4/26/2015)... (PRWEB) April 26, 2015 MidSouth ... grow throughout the Southeast. MidSouth Pain Treatment Center is ... in Cordova, Southaven, Oxford and Jackson, two ambulatory surgery ... in the Southaven and Cordova locations. , Dr. ... ”I went into medicine to help people, and when ...
(Date:4/25/2015)... Avid Collector Andrew Hawley from Vintage Rock ... Coliseum concert posters. The concert was held on 12 ... American Tour. , According to Hawley, “The poster ... Maryland. This poster blank was used to advertise the ... uses garish lettering and colors on this boxing style ...
(Date:4/25/2015)... (PRWEB) April 25, 2015 In the ... twelve and above needed treatment for an illicit ... the Substance Abuse and Mental Health Services Administration’s Survey ... Beyond these alarming numbers are harrowing stories of men ... substance abuse . David H. Kerr , founder ...
(Date:4/25/2015)... 25, 2015 By definition, a CIO’s responsibility ... the enterprise relying on their judgement and expertise to keep ... according to an article published in National Mortgage News ... be doing a disservice to their responsibilities by focusing too ... t’s are crossed when it comes to company policy and ...
Breaking Medicine News(10 mins):Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 4Health News:Growing Pains for MidSouth Pain Treatment Center 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 2Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 4Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 5
... CLEVELAND, Sept. 6 Cleveland Clinic Press,( ... ( http://www.clevelandclinic.org/ ), has just released "Write ... Journal Writing" by Dr.,Sheppard B. Kominars ( ... powerful insights and techniques for personal transformation ...
... Par,Pharmaceutical Companies, Inc. (NYSE: PRX ) today filed ... Report on Form 10-K. The,filing of Par,s Form 10-K ... in restating its consolidated financial statements for certain,prior periods, ... file its,Form 10-Q for the first and second quarters ...
... ANA, Calif., Sept. 6 Responding to increasing,needs ... in the number of people it,serves, Regional Center ... expand and improve the support it provides to ... 1. Special Education Advocacy. RCOC launched a program ...
... the patient real benefit, too , THURSDAY, Sept. 6 ... disease report better physical health if they participate in ... the health of spouse caregivers through counseling and support ... who are in poor health are more likely to ...
... Richard Trumka to Keynote Canadian, British, Australian RNs Describe ... ... Emotional September 11th Rally With a,Plea for Politicians to Focus ... 6 The California Nurses,Association/National Nurses Organizing Committee will convene ...
... consumers ... and business owners in the U.S., HOUSTON, Sept. 6 ... or partially insured consumers and,business owners substantial savings on healthcare, ... Insurance,Brokers, Inc. (IGIB). Based in Chula Vista, CA, IGIB is ...
Cached Medicine News:Health News:Cleveland Clinic Press Releases Journal-Writing Book 'Write for Life: Healing Body, Mind, and Spirit Through Journal Writing' by Sheppard B. Kominars, Ph.D. 2Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 2Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 3Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 4Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 5Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 6Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 7Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 8Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 9Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 10Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 11Health News:Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007 12Health News:Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs 2Health News:Counseling Boosts Alzheimer's Caregivers' Health 2Health News:Hundreds of RNs from Across U.S. and World to Join California Nurses Association/NNOC National Convention 2Health News:International Gateway Insurance Brokers Partners With MEDILINQ 2Health News:International Gateway Insurance Brokers Partners With MEDILINQ 3
... Allowing your patients to focus ... between the way the eyes ... vision enhancement to a remarkable ... restore your patients vision to ...
... lenses are manufactured using the ... Perspex CQ UV PMMA material ... and single piece lenses. Unioptic ... both nonphaco and phaco styles. ...
Optical implants for the replacement of the human crystalline lens in the visual correction of aphakia....
1% Sodium Hyaluronate, 10mg/mL, sterile opthalmic injection...
Medicine Products: